Next generation sequencing for detection of human primary immunodeficiency syndromes characterized by impaired cytotoxic lymphocyte function

Projektinformationen

SEQ-CYTOTOX

ID Finanzhilfevereinbarung: 311335

Projekt abgeschlossen

Startdatum 1 Mai 2013

Enddatum 30 April 2018

Finanziert unter

• Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Gesamtkosten € 1 499 996,00

EU-Beitrag € 1 499 996,00

Koordiniert durch

KAROLINSKA INSTITUTET
Sweden